
Granza Bio recently launched!
Founded by Ashwin Nandakumar and Ashwin Jainarayanan
~50% of cancer patients receive treatments that are (1) ineffective and (2) lead to unwanted and avoidable side effects.
(1) High mortality rates: Ineffective treatments lead to cancer relapse and ultimately, increased likelihood of dying from cancer. Five-year survival rates are lower than 5% for patients with late-stage cancers including lung, pancreas, and brain cancer.
(2) Toxicity and adverse side effects: While emerging treatments such as immunotherapy and CAR-T cell therapy are effective in some patients, they also impact their healthy tissues. This causes high toxicity and adverse side effects.
They have identified attack particles ⚡: a powerful suite of weapons in our immune system’s arsenal. These attack particles carry proteins like granzymes and perforins that instantly kill cancer cells.
Watch how it works! ⤵️
💀 High cancer-killing efficacy in brain, ovarian, lung, and skin cancers.
⚙ Engineered to target only the cancer cells, leaving the surrounding healthy cells untouched, meaning no toxicity or adverse side effects.
🧠 Capable of targeting brain cancers by crossing the blood-brain barrier.
🎯 Perfectly suited to a platform approach meaning they can use attack particles to target a great range of diseases including cancers, autoimmune diseases, and infections.
🏭 Highly stable and easy to manufacture.
